RESCIND
22 Dec 2020
Trial Summary
Resistant Starch for Chemotherapy Induced diarrhoea: a feasibility study
Acronym:
RESCIND
ACTRN/NCT /ethics:
N/A
Scientific title:
Resistant Starch for Chemotherapy Induced diarrhoea: a feasibility study
Sponsor / Cooperative group:
N/A
Trial & Patient Characteristics
| Cancer Type | All cancers |
|---|---|
| Trial Type | Early detection, diagnosis, prognosis |
| Phase | - |
| Age Range | All ages |
| Sex | All |
| Tumour Stream | - |
| Cancer Stage | - |
| Anticipated Start Date | - |
| Anticipated End Date | - |
Participating Hospitals
| Hospital | Flinders Medical Centre |
|---|---|
| Clinical Trial Coordinator | Alex Scott-Hoy |
| alex.scott-hoy@sa.gov.au | |
| Phone | 08 8204 4830 |
| Principal Investigator | Dr Amitesh Roy |
| Recruitment Status | Recruiting |